Serious fungal infections cause 1.3 million deaths annually worldwide.
Researchers have identified a new class of antifungals to treat the more than 300 million people worldwide who develop serious fungal infections
The research is described in the current issue of mBio, the online open-access journal of the American Society for Microbiology.
“Fungal infections are a significant cause of morbidity and mortality worldwide and current antifungal drugs have drawbacks. These new drugs may pave the way for the development of a new class of antifungals,” said principal investigator Maurizio Del Poeta, MD, a professor in the Department of Molecular Genetics and Microbiology at Stony Brook University, Stony Brook, New York.
Fungal infections are most commonly found in individuals with medical conditions that compromise the immune system, such as AIDS, or individuals who are being treated with immunosuppressives, such as those battling cancer. The three classes of antifungal drugs currently available—azoles, polyenes, and echinocandins—are far from optimal.
“Even with treatment, the mortality rate of invasive fungal infections is over 50%,” said Dr. Del Poeta. “The drugs don’t work that well. They are toxic, so they affect other organs, and they are static, meaning they may be able to stop a fungus from replicating but they are not able to kill the fungus.” Current antifungals also have a narrow spectrum of activity, and some interact with other drugs such as chemotherapy agents and immunosuppressants.”
Previous research has shown that when fungal cells lack a lipid called glucosylceramide (GlcCer), they are unable to replicate. Seeking to exploit this weakness and develop a new class of antifungals, an international group of researchers screened a synthetic drug library for compounds that target the synthesis of fungal but not mammalian GlcCer. “The enzymes that are important for the synthesis of fungal glucosylceramide are different than the ones important for the synthesis of mammalian glucosylceramide,” said Dr. Del Poeta. “We thought that because the pathway is totally different, we could specifically target the fungal glucosylceramide without affecting mammalian glucosylceramide, and that is exactly what we did.”
They identified two compounds, BHBM and its derivative DO, that decreased levels of fungal but not mammalian glucosylceramide. In test tube and animal studies, these compounds were highly effective against several pathogenic fungi and were well tolerated in animals. The drugs were effective when used alone or in combination with other classes of antifungals. The researchers plan to spend the next five years fine-tuning their research and identifying even more effective compounds that inhibit fungal glucosylceramide.
Serious fungal infections cause 1.3 million deaths annually worldwide. The most common and life-threatening fungal infections are cryptococcosis, candidiasis, aspergillosis, and pneumocystosis.
Read more: Researchers Identify New Class of Antifungal Agents
The Latest on: Antifungals
[google_news title=”” keyword=”Antifungals” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antifungals
- What Causes Swollen Lymph Nodes in the Armpit?on May 16, 2024 at 11:00 pm
The lymph nodes are small glands that are part of the immune system. They may become swollen from infections, autoimmune conditions, medication reactions, or cancer.
- Prince William's Latest Royal Appearance Had a Special Connection to His Childrenon May 16, 2024 at 10:57 am
According to Imperial College London, AMR occurs when infection-casing microorganisms become resistant to treatments and medications, such as antibiotics and antifungals. "Unless we act now and ...
- Prince William Steps Out to Support Cause Connected to Hospital Where George, Charlotte and Louis Were Bornon May 16, 2024 at 5:32 am
Prince William attended an event at The Royal Society in London on May 16 in connection to The Fleming Initiative, of which he is a patron. The Initiative was created to find a way to prevent ...
- FEND Act Against Fentanyl Trafficking Could Worsen Overdose Crisison May 15, 2024 at 11:07 am
Experts say it could just displace and diversify production, leading to less familiar, more potent drugs in the supply.
- The deadly price of a perfect strawberryon May 15, 2024 at 4:50 am
“It’s not like there aren’t other agricultural antifungals that can be used to make sure your berries are pristine.” A spokesperson for the APVMA said: “Should evidence emerge in relation to a role ...
- Combination Antifungal Therapy for Invasive Fungal Infections in Children and Adultson May 14, 2024 at 5:00 pm
[87] Nikkomycin Z, a chitin synthase inhibitor, has been evaluated with various combinations of other antifungals and demonstrated synergy with caspofungin and micafungin. [91] A very recent ...
- 'The most critically harmful fungi to humans': How the rise of C. auris was inevitableon May 11, 2024 at 4:00 am
"The march of drug-resistant C. auris clearly isn't slowing. If anything, it's rapidly speeding up. How did a fungus, so deadly to immunocompromised humans, just suddenly appear? And why was it ...
- Keto Diet Boosts Lifesaving Antifungal Drug in Miceon May 9, 2024 at 9:07 am
It’s possible that a keto diet influences the gut microbiome in a way that changes how the drug is absorbed. The dietary shift could also boost the immune system, making it easier for the drug to ...
- Vaginal Itching and Burningon May 7, 2024 at 5:00 pm
If the itching is caused by an infection, treatment with antibiotics, antifungals, or an antiparasitic usually will help get rid of it. People can be allergic to sperm, but it's rare. When someone ...
- Allergy to Imidazole Antifungals Retained in Shoeson April 19, 2024 at 4:59 pm
Topical imidazole antifungals are commonly used as first-line over-the-counter treatment of foot dermatoses. Patients may not provide a history of using these agents, but such agents can persist ...
via Bing News